Author: Naomi Diaz

Tempus AI and the University of Southern California in Los Angeles have launched a collaboration to advance precision medicine using artificial intelligence. The partnership will integrate AI-driven tools across the University of Southern California’s health system, which serves more than…

Mount Sinai Health System, based in New York City, will adopt an artificial intelligence-powered platform from SOPHiA GENETICS to expand its cancer research and genomic testing capabilities. The health system plans to use the SOPHiA DDM Platform to strengthen next-generation…

Signature Healthcare is responding to a cybersecurity incident that has disrupted portions of its information systems, prompting the Brockton, Mass.-based health system to shift to manual operations while continuing patient care. The health system identified suspicious activity in part of…

Tempus and New York City-based NYU Langone Health have formed a multi-year strategic collaboration to advance cancer research through molecular profiling and data-driven insights. The partnership will support NYU Langone Health’s Center for Molecular Oncology at the Laura and Isaac…

New York City-based Mount Sinai’s Tisch Cancer Center has launched a new AI platform designed to help more cancer patients across its health system find and enroll in clinical trials. The platform, called PRISM, uses an oncology-specific large language model…

The University of Texas MD Anderson Cancer Center in Houston is partnering with SOPHiA GENETICS to advance the use of artificial intelligence in cancer diagnostics and research. Through the collaboration, MD Anderson will work with the precision medicine company to…

Amazon launched an FDA-approved clinical trial for its cancer vaccines.